ES2052544T3 - Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas. - Google Patents

Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas.

Info

Publication number
ES2052544T3
ES2052544T3 ES87200128T ES87200128T ES2052544T3 ES 2052544 T3 ES2052544 T3 ES 2052544T3 ES 87200128 T ES87200128 T ES 87200128T ES 87200128 T ES87200128 T ES 87200128T ES 2052544 T3 ES2052544 T3 ES 2052544T3
Authority
ES
Spain
Prior art keywords
heterociclil
compositions containing
piperidinamines
histaminic
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87200128T
Other languages
English (en)
Inventor
Frans E Janssens
Jozef F Hens
Joseph L G Torremans
Jozef J P Heykants
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2052544T3 publication Critical patent/ES2052544T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES ANTIHISTAMINICAS QUE CONTIENEN, COMO INGREDIENTE ACTIVO UNA N-HETEROCICLIL -4PIPERIDINAMINA DE FORMULA (I), EN LA QUE L ES HIDROGENO, C1-6 ALQUILOXICARBONILO O FENILMETOXICARBONILO; A1=A2-A3 = A4 ES UN RADICAL DIVALENTE QUE TIENE LA FORMULA -CH=CH-CH=CH- (A) -N=CH-CH=CH- (B) -CH=N-CH=CH- (C) -CH=CH-N=CH- (D) O -CH=CH-CH=N- (E), UNA SAL DE LA MISMA, FARMACOLOGICAMENTE ACEPTABLE OBTENIDA POR ADICION DE ACIDO Y LA POSIBLE FORMA ESTEREOQUIMICAMENTE ISOMERA; METODOS PARA PREPARAR DICHOS COMPUESTOS Y COMPOSICIONES FARMACOLOGICAS; NUEVOS COMPUESTOS DE FORMULA (I).
ES87200128T 1986-02-03 1987-01-28 Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas. Expired - Lifetime ES2052544T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82549186A 1986-02-03 1986-02-03

Publications (1)

Publication Number Publication Date
ES2052544T3 true ES2052544T3 (es) 1994-07-16

Family

ID=25244134

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87200128T Expired - Lifetime ES2052544T3 (es) 1986-02-03 1987-01-28 Composiciones anti-histaminicas que contienen n-heterociclil-4-piperidinaminas.

Country Status (26)

Country Link
EP (1) EP0232937B1 (es)
JP (2) JPH0794393B2 (es)
CN (1) CN1018614B (es)
AT (1) ATE79620T1 (es)
AU (1) AU583706B2 (es)
CA (1) CA1327579C (es)
CY (1) CY1865A (es)
DE (1) DE3781173T2 (es)
DK (1) DK173674B1 (es)
EG (1) EG17993A (es)
ES (1) ES2052544T3 (es)
FI (1) FI870448A7 (es)
GR (1) GR3006158T3 (es)
HK (1) HK114695A (es)
HU (1) HU201067B (es)
IE (1) IE60885B1 (es)
IL (1) IL81448A (es)
MA (1) MA20868A1 (es)
NO (1) NO870407L (es)
NZ (1) NZ219165A (es)
PH (1) PH24738A (es)
PT (1) PT84234B (es)
TN (1) TNSN87015A1 (es)
ZA (1) ZA87744B (es)
ZM (1) ZM1287A1 (es)
ZW (1) ZW2087A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
US4897401A (en) * 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
US4988689A (en) * 1987-07-01 1991-01-29 Janssen Pharmaceutica N.V. ((Pharmacologically active bicyclic heterocyclic)methyl and -heteroatom) substituted hexahydro-1H-azepines and pyrrolidines
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
PH30434A (en) * 1989-04-07 1997-05-09 Janssen Pharmaceutica Nv Hydroxyalkylfuranyl derivatives
IT1229231B (it) * 1989-05-08 1991-07-26 Dompe Farmaceutici Spa Aminoimidazopiridine farmacologicamente attive
CA2043564A1 (en) * 1990-07-06 1992-01-07 Alfons G. M. De Knaep 3-[(5-methyl-2-furanyl)methyl]-n-(4-piperidinyl)-3h-imidazo [4,5-b]-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
NZ239540A (en) * 1990-09-24 1993-11-25 Neurosearch As 1-phenyl benzimidazole derivatives and medicaments
ATE257704T1 (de) * 1992-09-03 2004-01-15 Sepracor Inc Pharmazeutische zusammensetzungen enthaltend norastemizol.
AU730229B2 (en) * 1992-09-03 2001-03-01 Sepracor, Inc. Use of norastemizole for the treatment of allergic disorders
CA2161876A1 (en) * 1993-05-20 1994-12-08 Den-Ichi Momose 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
TW429256B (en) * 1995-12-27 2001-04-11 Janssen Pharmaceutica Nv 1-(1,2-disubstituted piperidinyl)-4-(benzimidazolyl- and imidazopyridinyl)-piperidine derivatives
EP1035869A1 (en) * 1997-03-26 2000-09-20 Sepracor, Inc. Chemically and thermally stable norastemizole formulations
US5817823A (en) * 1997-04-17 1998-10-06 Sepracor Inc. Method for synthesizing 2-substituted imidazoles
JP2003503403A (ja) 1999-06-28 2003-01-28 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 呼吸合胞体ウイルス複製阻害剤
EP1418175A1 (en) * 1999-06-28 2004-05-12 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
MXPA02000120A (es) 1999-06-28 2002-07-02 Janssen Pharmaceutica Nv Inhibidores de la replicacion del virus sincitial respiratorio.
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
EP1638939A2 (en) * 2003-06-24 2006-03-29 Neurosearch A/S Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
DK2161273T3 (en) 2003-12-22 2015-07-20 Leuven K U Res & Dev Imidazo [4,5-C] pyridine compounds and methods for antiviral therapy
PT1841765E (pt) 2004-12-21 2009-05-14 Gilead Sciences Inc Anticorpos para mcp-1 humano
EP1838706A1 (en) * 2004-12-24 2007-10-03 Prosidion Limited G-protein coupled receptor agonists
NZ556628A (en) 2005-03-08 2009-09-25 Janssen Pharmaceutica Nv Diaza-spiro-[4.4]-nonane derivatives as neurokinin (NK1) antagonists
US7754720B2 (en) 2006-07-07 2010-07-13 Gilead Sciences, Inc. Pyridazine compound and use thereof
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
CN102361857B (zh) * 2008-09-26 2015-09-16 默沙东公司 可用作抗糖尿病剂的环状苯并咪唑衍生物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4219559A (en) * 1979-01-10 1980-08-26 Janssen Pharmaceutica N.V. N-Heterocyclyl-4-piperidinamines
IN156065B (es) * 1982-07-12 1985-05-04 Janssen Pharmaceutica Nv
US4556660A (en) * 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) * 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
EP0144101B1 (en) * 1983-11-30 1991-02-06 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing n-(bicyclic heterocyclyl)-4-piperidinamines
JPS60174778A (ja) * 1984-01-09 1985-09-09 ジヤンセン・フア−マシユ−チカ・ナ−ムロ−ゼ・フエンノ−トシヤツプ Ｎ−ヘテロシクリル−４−ピペリジンアミン
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4588722A (en) * 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives

Also Published As

Publication number Publication date
AU583706B2 (en) 1989-05-04
PT84234A (en) 1987-03-01
TNSN87015A1 (fr) 1990-01-01
ZW2087A1 (en) 1988-08-31
FI870448A0 (fi) 1987-02-02
DK173674B1 (da) 2001-06-05
ZM1287A1 (en) 1988-08-29
CN1018614B (zh) 1992-10-14
FI870448A7 (fi) 1987-08-04
IE60885B1 (en) 1994-08-24
EP0232937A3 (en) 1988-04-06
NZ219165A (en) 1990-04-26
CN87100563A (zh) 1987-08-19
PT84234B (pt) 1989-09-14
NO870407L (no) 1987-08-04
IE870258L (en) 1987-08-03
CA1327579C (en) 1994-03-08
AU6821887A (en) 1987-08-06
DK54187D0 (da) 1987-02-02
JPH0819126B2 (ja) 1996-02-28
EP0232937A2 (en) 1987-08-19
HK114695A (en) 1995-07-21
JPH07179458A (ja) 1995-07-18
HUT44544A (en) 1988-03-28
EP0232937B1 (en) 1992-08-19
NO870407D0 (no) 1987-02-02
IL81448A0 (en) 1987-09-16
EG17993A (en) 1991-08-30
JPH0794393B2 (ja) 1995-10-11
ATE79620T1 (de) 1992-09-15
JPS62215575A (ja) 1987-09-22
MA20868A1 (fr) 1987-10-01
DE3781173T2 (de) 1992-12-17
PH24738A (en) 1990-10-01
DE3781173D1 (de) 1992-09-24
GR3006158T3 (es) 1993-06-21
ZA87744B (en) 1988-10-26
DK54187A (da) 1987-08-04
CY1865A (en) 1996-04-05
IL81448A (en) 1990-09-17
HU201067B (en) 1990-09-28

Similar Documents

Publication Publication Date Title
LV11035A (lv) Jauni benzimidazolin-2-okso-1-karbonskabes atvasinajumi kuri pielietojami ka serotonina (5-HT) receptoru antagonisti
ES516131A0 (es) Un procedimiento para la preparacion de nuevas n-(4-piperidinil) benzamidas.
GT200000002A (es) Ureas difenilicias x - carboxyaril sustituidas como inhibidores raf kinase.
EA200200087A1 (ru) Ингибиторы репликации респираторно-синцитиального вируса
ES2059489T3 (es) Derivados bencimidazol 1-alkil sustituidos.
PT88577A (pt) Process for the manufacture of novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
AR011409A1 (es) Derivados de 16-hidroxi-11-(fenil substituido)-estra-4,9-dieno, su utilizacion, un procedimiento para prepararlos, formulaciones farmaceuticasque comprenden a dichos derivados, y un compuesto utilizable como intermediario para prepararlos
DK0808303T3 (da) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansyrederivater som tachykininreceptorantagonister
NO882641D0 (no) Nye n-(4-piperidinyl)bisyklisk kondensert 2-imidazilaminderivater.
EP0337136A3 (en) Piperidine derivatives in the treatment of extrapyramidal side effects associated with neuroleptic therapy
ES452602A1 (es) Procedimiento para la preparacion de nuevos derivados pipe- ridinicos tetraciclicos.
DK408083D0 (da) Isoquinilinderivater, deres fremstilling og anvendelse
ATE27806T1 (de) Norbornan- und norbornencarbonsaeureamide und verfahren zu deren herstellung.
ZA852561B (en) Tetrahydrothienopyridines,a process for their preparation and their use as medicaments
PE107598A1 (es) Cetirizina util para el tratamiento de enfermedades de tipo virico
NO167286C (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzotiazepin-derivater.
ES432026A1 (es) Un procedimiento para la preparacion de anilinobenzotiazo- les.
ES2037758T3 (es) Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion.
GB1044964A (en) New aminoketones
ES8504754A1 (es) Procedimiento para preparar la n-(3-trifluorometil fenil)-n-propargil-piperazina.
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
ES430202A1 (es) Procedimiento para la preparacion de n-(heteroarilmetil - delta7-desoxi-normorfinas y -norcodeinas.
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
NO170848C (no) Blanding av organiske ammoniumsalter og deres anvendelse som stroemningsfremskyndere
ES380930A1 (es) Un procedimiento de preparacion de nuevas 2-hidroxi-5-aminobenzamidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 232937

Country of ref document: ES